HOB Biotech Group Corp Ltd (688656) — Cash Flow-to-Debt Ratio
HOB Biotech Group Corp Ltd (688656) has a Cash Flow-to-Debt Ratio of 0.14x as of December 2025, meaning its operating cash flow of CN¥15.28 Million could theoretically repay 0% of its total liabilities (CN¥111.30 Million) in one year. See HOB Biotech Group Corp Ltd (688656) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
HOB Biotech Group Corp Ltd Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for HOB Biotech Group Corp Ltd across 10 annual periods. For the full cash flow conversion analysis, see HOB Biotech Group Corp Ltd cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for HOB Biotech Group Corp Ltd (2016–2025)
Year-by-year debt coverage analysis for HOB Biotech Group Corp Ltd. Check HOB Biotech Group Corp Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.66x | CN¥72.94 Million | CN¥111.30 Million | ▲ +42.9% |
| 2024 | 0.46x | CN¥101.22 Million | CN¥220.67 Million | ▼ -38.1% |
| 2023 | 0.74x | CN¥102.69 Million | CN¥138.52 Million | ▲ +109.8% |
| 2022 | 0.35x | CN¥58.31 Million | CN¥164.99 Million | ▼ -68.3% |
| 2021 | 1.12x | CN¥104.79 Million | CN¥93.92 Million | ▲ +72.5% |
| 2020 | 0.65x | CN¥58.22 Million | CN¥90.02 Million | ▲ +25.9% |
| 2019 | 0.51x | CN¥68.57 Million | CN¥133.54 Million | ▲ +1.7% |
| 2018 | 0.50x | CN¥46.51 Million | CN¥92.10 Million | ▲ +47.9% |
| 2017 | 0.34x | CN¥22.26 Million | CN¥65.20 Million | ▲ +261.2% |
| 2016 | 0.09x | CN¥6.42 Million | CN¥67.94 Million | — |